Department of Physiology and Biophysics and the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama 35294-0005, USA.
J Biol Chem. 2010 Dec 24;285(52):40438-47. doi: 10.1074/jbc.M110.161497. Epub 2010 Oct 15.
The unique regulatory (R) domain differentiates the human CFTR channel from other ATP-binding cassette transporters and exerts multiple effects on channel function. However, the underlying mechanisms are unclear. Here, an intracellular high affinity (2.3 × 10(-19) M) Fe(3+) bridge is reported as a novel approach to regulating channel gating. It inhibited CFTR activity by primarily reducing an open probability and an opening rate, and inhibition was reversed by EDTA and phenanthroline. His-950, His-954, Cys-832, His-775, and Asp-836 were found essential for inhibition and phosphorylated Ser-768 may enhance Fe(3+) binding. More importantly, inhibition by Fe(3+) was state-dependent. Sensitivity to Fe(3+) was reduced when the channel was locked in an open state by AMP-PNP. Similarly, a K978C mutation from cytoplasmic loop 3 (CL3), which promotes ATP-independent channel opening, greatly weakened inhibition by Fe(3+) no matter whether NBD2 was present or not. Therefore, although ATP binding-induced dimerization of NBD1-NBD2 is required for channel gating, regulation of CFTR activity by Fe(3+) may involve an interaction between the R domain and CL3. These findings may support proximity of the R domain to the cytoplasmic loops. They also suggest that Fe(3+) homeostasis may play a critical role in regulating pathophysiological CFTR activity because dysregulation of this protein causes cystic fibrosis, secretary diarrhea, and infertility.
独特的调节(R)域将人类 CFTR 通道与其他 ATP 结合盒转运蛋白区分开来,并对通道功能产生多种影响。然而,其潜在机制尚不清楚。在这里,报道了一种细胞内高亲和力(2.3×10(-19) M)Fe(3+)桥作为调节通道门控的新方法。它主要通过降低开放概率和开放速率来抑制 CFTR 活性,抑制作用可被 EDTA 和菲咯啉逆转。His-950、His-954、Cys-832、His-775 和 Asp-836 被发现对抑制作用至关重要,磷酸化 Ser-768 可能增强 Fe(3+)结合。更重要的是,抑制作用具有状态依赖性。当通道被 AMP-PNP 锁定在开放状态时,对 Fe(3+)的敏感性降低。同样,来自细胞质环 3(CL3)的 K978C 突变,促进 ATP 非依赖性通道开放,大大减弱了 Fe(3+)的抑制作用,无论 NBD2 是否存在。因此,尽管 NBD1-NBD2 的 ATP 结合诱导二聚化是通道门控所必需的,但 Fe(3+)对 CFTR 活性的调节可能涉及 R 域和 CL3 之间的相互作用。这些发现可能支持 R 域与细胞质环的接近。它们还表明,Fe(3+)的动态平衡可能在调节病理生理 CFTR 活性中发挥关键作用,因为该蛋白的失调会导致囊性纤维化、分泌性腹泻和不育。